Answer
Blood pressure monitoring is recommended because ropinirole carries a risk of hypotension, particularly at treatment initiation in patients with severe cardiovascular disease, especially coronary insufficiency.
Sources for this answer
- Requip XL prolonged-release tabletsGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked